FTH1P18


Understanding FTH1P18: A Genetic Mutation Impacting Blood Clotting and Pregnancy

Description

FTH1P18 is a genetic mutation that occurs in the FTH1 gene, which provides instructions for making the clotting factor XIII protein. This protein plays a crucial role in the final stages of blood clot formation, ensuring the stability and strength of the clot. FTH1P18 affects the production and function of clotting factor XIII, leading to a condition known as factor XIII deficiency.

Associated Diseases

Factor XIII deficiency can result in a range of bleeding disorders, including:

  • Excessive bruising and bleeding from wounds
  • Heavy menstrual bleeding
  • Delayed wound healing
  • Bleeding after dental procedures or surgeries
  • Miscarriages and premature birth

Did you Know ?

Factor XIII deficiency affects approximately 1 in 2,000,000 people worldwide, making it a rare condition. However, it is the most common inherited bleeding disorder after hemophilia.



Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.